Zogenix (ZGNX)
Add to Watchlists Create an Alert
1.56
+0.05 +3.31%
NASDAQ
May 23, 2:46PM
BATS Real time
Currency in USD
Zogenix Cash from Financing Quarterly:
0.208M for Dec. 31, 2012Zogenix Historical Cash from Financing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 0.208M |
| Sept. 30, 2012 | 41.78M |
| June 30, 2012 | -2.946M |
| March 31, 2012 | -1.848M |
| Dec. 31, 2011 | 2.105M |
| Sept. 30, 2011 | 86.96M |
| June 30, 2011 | -0.676M |
| March 31, 2011 | 0.049M |
| Dec. 31, 2010 | 52.32M |
| Sept. 30, 2010 | 30.77M |
| June 30, 2010 | -1.739M |
| March 31, 2010 | -1.696M |
| Sept. 30, 2009 | 31.83M |
| June 30, 2009 | 10.30M |
About Cash From Financing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More
ZGNX Cash from Financing Quarterly Benchmarks
| Companies | |
|---|---|
| Johnson & Johnson | -777.00M |
| GlaxoSmithKline | -2.211B |
| Tetraphase Pharmaceuticals |
ZGNX Cash from Financing Quarterly Rankings
| Overall |
80th percentile 1560 of 8006 |
| Sector |
64th percentile 244 of 686 in Healthcare |
| Industry |
65th percentile 19 of 55 in Drug Manufacturers - Major |
ZGNX Cash from Financing Quarterly Range, Past 5 Years
| Minimum | -2.946M | Jun 2012 |
| Maximum | 86.96M | Sep 2011 |
| Average | 17.67M |
ZGNX News
Impax Labs (IPXL), Zogenix (ZGNX) Rise as FDA Won't Block Generic Opana (ENDP)
Street Insider May 10
Street Insider May 10